Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Merck & Company Inc (MRK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Merck&Co's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
127.01 +0.13    +0.10%
24/04 - Closed. Currency in USD ( Disclaimer )
After Hours
126.94
-0.07
-0.06%
0:55:59 - Real-time Data
  • Volume: 6,829,513
  • Bid/Ask: 125.64 / 126.99
  • Day's Range: 125.35 - 127.59
Type:  Equity
Market:  United States
Merck&Co 127.01 +0.13 +0.10%

NYSE:MRK Financials

 
This summary provides an overview of the most significant critical numbers from each of the Merck financial reports, including theMerck income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the NYSE:MRK financials over time via breakdowns of their annual reports.

Merck & Co., Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 14,630 million compared to USD 13,830 million a year ago. Net loss was USD 1,226 million compared to net income of USD 3,017 million a year ago.For the full year, sales was USD 60,115 million compared to USD 59,283 million a year ago. Net income was USD 365 million compared to USD 14,519 million a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

MRK Income Statement & Profits

Gross margin TTM 73.53%
Operating margin TTM 7.59%
Net Profit margin TTM 0.61%
Return on Investment TTM 4.99%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 14630 15962 15035 14487
Gross Profit 10835 11731 11043 10590
Operating Income 12 5824 -4816 3951
Net Income -1226 4745 -5975 2821

MRK Balance Sheet

Quick Ratio MRQ 0.73
Current Ratio MRQ 1.25
LT Debt to Equity MRQ 89.63%
Total Debt to Equity MRQ 96.51%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 106675 106727 104469 107796
Total Liabilities 69040 65427 65727 60891
Total Equity 37635 41300 38742 46905

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM 5.13
Revenue/Share TTM 23.72
Operating Cash Flow  0.96%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 246 7717 3704 1339
Cash From Investing Activities 53 -334 -11443 -2359
Cash From Financing Activities -2245 -4269 3758 -2054
Net Change in Cash -1760 2957 -4074 -2987
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MRK Price Commentary

Write your thoughts about Merck & Company Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Apr 19, 2022 20:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
down today because stupid like cow as dow jones components
Melvin Lim
Melvin Lim Oct 06, 2021 17:29
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just started. More to go!
Alan Ng
Alan Ng Sep 23, 2021 15:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it is going up
Tim Lo
Tim Lo Feb 22, 2021 16:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What happen to MRK ? Time to buy ?
amit saxena
amit saxena Oct 15, 2020 18:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it will cross 81 in coming days
Ali Asghar
Ali Asghar Oct 15, 2020 18:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hello
Mike Pieri
Mike Pieri Mar 04, 2019 2:57
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The immuno-oncology drugs are promising, but $81.65 seems a bit over-excited. It's no cure, just prolonging life a small amount in end-stage patients who were resistant to normal treatments. A pullback to $70 on the cards in the next 6months would be realistic.
Sukumar Jain
Sukumar Jain Mar 04, 2019 2:57
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nice input
Sukumar Jain
Sukumar Jain Mar 04, 2019 2:57
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nice input
Hossein Taheri
Hossein Taheri Jan 31, 2019 22:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It will be going up
jordan rrk
jordan rrk Dec 26, 2017 8:26
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Position buy will be up price
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email